FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

2.

Obesity-related cancer rising among both younger and older adults worldwide, study finds

3.

According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.

4.

AI-based liquid biopsy shows promise for detecting brain cancer

5.

Only 1 in 4 Eligible Adults Receive Lung Screening


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot